Introduction
Nuclear factor-kB (NF-kB) is a pleiotropic transcription factor. It is formed of homo or heterodimers derivd from a family of proteins which are all related to the viral v-Rel oncoprotein Miyamoto and Verma, 1995; Baldwin, 1996) . The members of the Rel/NF-kB family are, in humans, p50/ p105 (NFKB1), p52/p100 (NFKB2), p65 (RelA), RelB and c-Rel (Rel). p50 and p52 are derived from large cytoplasmic precursors, named p105 and p100 respectively, while p65 (RelA), RelB and c-Rel harbor transactivating domains.
NF-kB activity is tightly controlled by a group of inhibitory proteins belonging to the IkB family Baldwin, 1996) . Members of this family are IkB-a, IkB-b, IkB-e, Bcl-3, p105 and p100 Baldwin, 1996; Whiteside et al., 1997) . All these proteins are characterized by the presence of repetitive sequences named`Ankyrin Repeats' because they are similar to the human protein ankyrin (Lux et al., 1990) . The Ankyrin domain of the IkB proteins, with the exception of Bcl-3, covers the nuclear localization signal of NF-kB proteins and sequesters them in the cytoplasm (Haskill et al., 1991; Beg et al., 1992; Ganchi et al., 1992; Henkel et al., 1992; Lenardo and Siebenlist, 1994) . A large number of signals can liberate NF-kB from its IkB inhibitor and thus allow NF-kB nuclear translocation and transactivation of target genes (Baldwin, 1996; Siebenlist, 1997) .
IkB-a is the most studied IkB protein. Following cellular treatment with a number of reagents, IkB-a is rapidly phosphorylated on serines 32 and 36 (Brown et al., 1995; Traenckner et al., 1995) . This phosphorylation targets IkB-a for ubiquitination and degradation by the proteasome 26S (Traenckner et al., 1994; Alkalay et al., 1995; Chen et al., 1995; Scherer et al., 1995; Rodriguez et al., 1996; Ro et al., 1996) . This proteolysis is very fast and can be almost completed within minutes after cellular stimulation with agents such as TNF-a or IL-1 Thompson et al., 1995) . Following NF-kB activation, IkB-a is synthesized de novo and can recapture NF-kB complexes Sun et al., 1993) .
Alternatively, treatment with phosphatase inhibitors or reoxygenation of hypoxic cells can lead to IkB-a phosphorylation on tyrosine 42 (Imbert et al., 1996) . This phosphorylation leads to the dissociation of IkB-a from the NF-kB complex without degradation of the inhibitor. The biological relevance of tyrosine 42 phosphorylation remains to be established.
In response to extracellular stimuli, the IkB-b protein is phosphorylated on serines 19 and 23, ubiquitinated and degraded by the proteasome DiDonato et al., 1996; Weil et al., 1997) . These processes are much slower for IkBb than with IkB-a and occur in response to stimuli such as LPS, IL-1 or Tax that induce a sustained NFkB activation Good and Sun, 1996; McKinsey et al., 1996) . Similarly to IkB-a and IkB-b, IkB-e is phosphorylated on two serines in response to NF-kB-activating stimuli (Li and Nabel, 1997; Whiteside et al., 1997) . IkB-e preferentially interacts with p65 and c-Rel and is degraded with a slower kinetics than IkB-a (Whiteside et al., 1997) .
The Bcl-3 protein remains an exception within the IkB family. It associates with NF-kB inside the nucleus and directly participates in increasing gene transcription (Franzoso et al., 1992 Bours et al., 1993; Fujita et al., 1993; Nolan et al., 1993; Watanabe et al., 1997) .
The p105 and p100 precursor proteins are the other members of the IkB family. They both contain ankyrin repeats and sequester NF-kB complexes in the cytoplasm (Bours et al., 1990 Kieran et al., 1990; Neri et al., 1991; Schmid et al., 1991; Mercurio et al., 1992 Mercurio et al., , 1993 Rice et al., 1992) . These precursors are cleaved in order to liberate nuclear-prone p50 or p52 proteins (Fan and Maniatis, 1991; Mercurio et al., 1993) . p100 and p105 are able to heterodimerize with other NF-kB proteins and their ankyrin repeat domain inhibits nuclear translocation of such dimers. However, it has also been demonstrated that p100 can form trimeric cytoplasmic complexes with p50/p65 or with p50/RelB (Kanno et al., 1994; Dejardin et al., 1995 Dejardin et al., , 1998 . Despite reports showing p100 cleavage after phorbol ester stimulation in HeLa cells and p105 partial degradation by the proteasome pathway, little is known on the regulation of p100 or p105 processing in response to NF-kB-activating stimuli (Fan and Maniatis, 1991; Mercurio et al., 1993; Palombella et al., 1994) .
Recent reports showed a constitutive NF-kB activity in breast cancer cells and in Hodgkin's disease cells (Bargou et al., , 1997 Nakshatri et al., 1997; Sovak et al., 1997) . In these cells, the high NF-kB activity has been associated with low IkB-a expression and high IkB-a turnover . Constitutive NF-kB activity is required for cellular proliferation and protects cancer cells from apoptosis (Bargou et al., 1997; Sovak et al., 1997) .
We have previously reported a high expression of p100 in various breast cancer cell lines as well as in primary human breast adenocarcinomas (Dejardin et al., 1995) . In breast cancer cell lines, p100 sequesters NF-kB complexes in the cytoplasm. The present study shows that p100, when highly expressed, is the major NF-kB inhibitor in these cells. p100 is not processed following cellular stimulation with a number of NFkB-activating agents and therefore blocks NF-kBdependent transactivation of reporter genes.
Results

NF-kB activity and expression of IkB-related proteins in adenocarcinoma cells
The constitutive nuclear NF-kB activity in various adenocarcinoma cell lines was investigated by Electrophoretic Mobility Shift Assays (EMSAs) (Figure 1a) . Nuclear extracts were prepared from seven breast cancer cell lines (MCF7 A/Z, MDA-MB-231, MDA-MB-435, MDA-MB-453, MDA-MB-468, BT-474 and T47D), one ovarian carcinoma cell line (OVCAR-3) and four colon carcinoma cell lines (HT29, HTM29, HCT116 and SW480). The constitutive NF-kB activity was very high in some cell lines (MDA-MB-468, OVCAR-3, HTM29 and SW480), easily detectable in others (MDA-MB-231, MDA-MB-435, T47D and HCT116) and almost undetectable in a few cell lines (MCF7 A/Z, MDA-MB-453, BT-474 and HT29). The speci®city of the observed complexes was con®rmed on extracts from MDA-MB-468 cells by competition with an excess of unlabelled wild-type (wt) or mutated (mut) oligonucleotides. The large lower complex observed with MDA-MB-453 nuclear extracts and the kB probe is not speci®c. EMSAs performed with an Oct-1 probe and with an AP-1 probe showed that appropriate amounts of nuclear proteins were extracted from the various cell lines (Figure 1a) .
The expression of various IkB-related proteins in the cytoplasm of the same adenocarcinoma cell lines was explored by immunoblots ( Figure 1b) . Expression of IkB-a, IkB-b, p100 and p105 was detected in all the cell Figure 1 Constitutive NF-kB nuclear activity and expression of IkB proteins in adenocarcinoma cell lines. Nuclear and cytoplasmic extracts were prepared from the mentioned adenocarcinoma cell lines and analysed by EMSAs for NF-kB activity (a) or by immunoblots for the expression of IkB-a, IkB-b, p100 and p105 (b). (a) Nuclear proteins (10 mg) from the mentioned cells were analysed on EMSAs with a labelled kB, Oct-1 or AP-1 probe. Competitions were performed with a 206 molar excess of unlabelled wild type (wt) or mutated (mut) probe mixed with the nuclear extracts from MDA-MB-468 cells. (b) Equal amounts of cell extracts (10 mg for IkB-a, p100 and p105 and 20 mg for IkB-b) were loaded on each lane and analysed by immunoblots revealed with speci®c antibodies. Speci®c bands are indicated in the ®gure. p52 and p50 refer to the processed forms of p100 and p105, respectively lines at dierent levels. IkB-a expression was very high in MCF7 A/Z, MDA-MB-453, BT-474, T47D and HCT116 cells while IkB-b was highly expressed in MDA-MB-435, MDA-MB-468, OVCAR-3 and HTM29 cells. p100 was expressed at high levels, as previously described (Dejardin et al., 1995) , in MDA-MB-231 and MDA-MB-435 cells but also in T47D, OVCAR-3, HTM29 and HCT116 cells. p105 expression was more or less identical in the dierent cell lines and in all cases, with the exception of BT-474 cells, p50 was expressed at higher levels than p105 indicating a rapid and constitutive processing of the precursor protein in adenocarcinoma cells. Interestingly, in some cell lines, one inhibitor seemed to be predominant: IkBa in MCF7 A/Z, MDA-MB-453 and BT-474 cells and IkB-b in MDA-MB-468 and HTM29 cells. MDA-MB-435 and OVCAR-3 cells are characterized by a low expression of IkB-a together with high levels of p100.
Control of the p50/p65 transcriptional activity by the IkB-related proteins
In order to compare the eect of the various IkBrelated proteins, expression vectors for p50, p65 and IkB-a, IkB-b, p105 or p100 were cotransfected in the Cos-7 cells together with a reporter plasmid containing the three kB sites from the ICAM-1 promoter cloned upstream of a minimal thymidine kinase promoter and a luciferase (LUC) reporter gene (3xNF-kB(pIC)-tk-LUC). The Cos-7 cells constitute a very clean NF-kB naive system as they express very low levels of NF-kB and IkB proteins. In these conditions, coexpression of p50 and p65 led to a 90-fold induction of the LUC activity as compared to the cells transfected with the reporter plasmid alone (Figure 2 ). Increasing amounts of expression vectors for IkB-a, IkB-b or p100 completely abolished NF-kB-dependent transactivation in a dose-dependent manner while p105 did not demonstrate any inhibitory activity in these experimental conditions unless very high amounts of the expression vector was transfected (Figure 2 ). Similar data were obtained after transfection of MCF7 A/Z cells with p50/p65 and IkBa, p100 or p105 (data not shown).
These data therefore suggest that IkB-a, IkB-b and p100 are potent inhibitors of NF-kB in Cos-7 and MCF7 A/Z cells while p105 is not. It is thus likely that p105 is rapidly processed into p50 in these cells and can associate with NF-kB-related transactivating proteins. Indeed, immunoblots performed on untransfected MCF7 A/Z cells showed a large excess of p50 compared to p105 (see Figure 1b) .
p65 cytoplasmic sequestration led by IkB-related proteins
In order to identify the role of the dierent inhibitors of p65, cytoplasmic extracts from the dierent adenocarcinoma cell lines were immunoprecipitated with an anti-p65 antibody and analysed for the presence of IkB-a and p100 in the precipitated material. In some cell lines, which express high amounts of IkB-a, most of p65 was indeed sequestered by IkB-a (MCF7 A/Z, MDA-MB-453, BT-474) while in other cells, p100 is the major p65 inhibitor (MDA-MB435, MDA-MB-468, SW480) ( Figure 3 ).
Induction of NF-kB in various adenocarcinoma cell lines
To investigate whether dierences in IkB proteins expression translated into dierences in NF-kB activity, MCF7 A/Z, T47D, MDA-MB-435 and Figure 2 Inhibition of NF-kB-dependent transactivation by IkB proteins. Cos-7 cells were transfected with expression vectors for p50 and p65 (5 pmol each) together with the 3xNF-kB(pIC)-tk-LUC reporter plasmid (0.5 mg). Increasing amounts of expression vectors for IkB-a, IkB-b, p100, or p105 were cotransfected (2, 10, 20, 30 and 40 pmol) as indicated in the ®gure. The total amount of transfected DNA (3 mg) was kept constant throughout the experiment by adding appropriate amounts of the expression vector without insert. The ®gure shows the relative luciferase activity over the activity observed with the luciferase vector alone after normalization to the protein concentration of the extracts. Each column represents the mean of three independent experiments (+s.d.), each experiment comparing the dierent inhibitors in a single set of transfections MDA-MB-231 cells were stimulated with TNF-a for various times and nuclear extracts were analysed by EMSA. In all four cell lines, TNF-a rapidly induced NF-kB nuclear DNA-binding activity (Figure 4) . Supershifting experiments showed that the induced complexes were mainly formed of p50 homodimers (lower faint band) and of p50/p65 heterodimers (upper strong band) (Figure 4) . The four gels shown in Figure  4 were run simultaneously after incubation of the nuclear extracts with the same kB probe, exposed for the same time and amounts of loaded proteins were normalized throughout. A similar pattern was observed after cell stimulation with PMA (data not shown). In these conditions, it is clear that NF-kB induction was stronger in cells where a large proportion of p65 is complexed with IkB-a (MCF7 A/Z and T47D) ( Figure  4a and c) than in cells where p100 is the major p65 inhibitor (MDA-MB-435 and MDA-MB-231) ( Figure  4b and d).
In order to check which IkB proteins were degraded in response to TNF-a stimulation, cytoplasmic extracts from TNF-a-treated MDA-MB-435 cells were prepared and analysed by immunoblots ( Figure 5 ). In these conditions, TNF-a induced a rapid and almost complete degradation of IkB-a ( Figure 5 , top panel). IkB-b was also degraded but with a slower kinetics. However, p100 and p105 did not show any detectable processing after TNF-a treatment (Dejardin et al., 1995) (Figure 6 and data not shown). In these cells, despite high basal expression of p100, the induction of nuclear DNA-binding activity was thus exclusively linked to IkB-a and IkB-b degradation. Immunoblots performed on nuclear extracts from the same cells con®rmed that some p50 and p65 proteins translocated to the nucleus following TNF-a stimulation ( Figure 5 and data not shown). However, most of p65 remained in the cytoplasm, probably as a consequence of its sequestration by unresponsive p100.
To evaluate the relative stability of the dierent NFkB inhibitors, the half-lives of p100 and IkB-a were measured in MDA-MB-435 cells ( Figure 6 ). The cells Figure 3 p65 coimmunoprecipitates with IkB proteins in adenocarcinoma cell lines. Cytoplasmic extracts (300 mg) were prepared from the mentioned adenocarcinoma cell lines and immunoprecipitated with a speci®c antibody against p65. The immunoprecipitated material was then analysed on immunoblots for the presence of IkB-a or p100. These immunoprecipitations were performed with two dierent anti-p65 antibodies, directed against an amino-terminal (see ®gure) or a carboxy-terminal peptide (data not shown). The speci®city of the precipitated complexes was con®rmed by competition with an excess of peptide Figure 1(a) . For competition assays, a 206 molar excess of unlabelled wild type (wt) or mutated (mut) probe was added to the binding reactions containing nuclear extract from cells stimulated for 360 min. For this experiment, nuclear extracts from the four cell lines were incubated for the same time with the same labelled kB probe and the four gels shown were run simultaneously and exposed for the same time (0) or stimulated with TNF-a for the indicated times were analysed on immunoblots with antibodies directed against IkB-a, IkB-b and p65. Equal amounts of cell extracts (10 mg for IkB-a and p65, and 20 mg for IkB-b) were loaded on each lane. Speci®c bands are indicated in the Figure   Figure 6 p100 and IkB-a stability in MDA-MB-435 cells. MDA-MB-435 cells were incubated in the presence of cycloheximide (100 mg/ml). Cytoplasmic extracts were prepared at the indicated times and analysed for the expression of p100 and IkB-a. p100 and IkB-a stability was also evaluated after treatment with TNF-a in the presence of cycloheximide (right panels)
were treated with cycloheximide in order to inhibit de novo protein synthesis and cytoplasmic extracts were prepared after increasing times of incubation as indicated in the ®gure. This experiment con®rmed that p100 was very stable (Figure 6 , left panel). Interestingly, simultaneous stimulation with TNF-a did not modify the rate of p100 degradation (right panel). In the same experiment, we showed a spontaneous progressive degradation of IkB-a in the presence of cycloheximide while TNF-a stimulation induced a rapid degradation of IkB-a (Figure 6 ). Similar data on IkB-a and p100 stability were obtained in unstimulated and TNF-a-treated MCF7 A/Z cells (data not shown).
Impaired TNF-a-induced NF-kB-dependent transactivation in cells expressing p100
To investigate whether the dierences in in vitro NF-kB DNA-binding activation corresponded to modi®cations of its transcriptional properties, MCF7 A/Z and MDA-MB-435 cells were transfected with an NF-kBdependent reporter plasmid containing the two kB sites from the HIV-LTR upstream of a CAT reporter gene (HIV-kB-CAT) and stimulated with several NF-kBinducing compounds. As shown on Figure 7a , stimulation of MCF7 A/Z cells with TNF-a, PMA and IL-1b induced a 5 ± 6-fold increase in CAT activities. However, the same stimuli failed to induce any CAT activity in MDA-MB-435 cells. Similarly, NF-kB-dependent transcriptional activity could not be induced after stimulation with PMA and TNF-a of MDA-MB-231 cells which also expressed high p100/ IkB-a ratios (data not shown).
As these results could be related to pecularities of the HIV-kB-CAT reporter plasmid, MCF7 A/Z and MDA-MB-435 cells were transfected with the 3xNF-kB(pIC)-tk-LUC reporter plasmid. Again, cellular stimulation with TNF-a and PMA strongly induced the LUC activity in MCF7 A/Z cells but generated only very weak transactivation in MDA-MB-435 cells (Figure 7b ). In the same conditions, TNF-a stimulation did not generate any transcription of a tk-LUC reporter gene (data not shown). These data were further reproduced with other NF-kB-dependent reporter plasmids in which the CAT gene was driven by either the kB site from the IL-2, IL-2R or immunoglobulin light chain gene promoter, by a Figure 7 Relative NF-kB transcriptional activity after stimulation with TNF-a, IL-1b or PMA. MCF7 A/Z and MDA-MB-435 cells were transfected with a reporter plasmid containing a CAT gene driven by the two kB sites from the HIV virus upstream of a minimal c-fos promoter (HIV-kB-CAT) (a), or with a reporter plasmid containing a luciferase gene driven by the three kB sites from the ICAM-1 promoter upstream of a minimal thymidine kinase promoter (3xNF-kB(pIC)-tk-LUC) (b). The cells were stimulated with TNF-a, IL-1b or PMA for 6 h at 378C and then harvested. The ®gure shows the relative reporter activity after stimulation over the activity observed without stimulation. Each value represents the mean of a minimum of three independent experiments after normalization to the protein concentration of the extracts palindromic kB site or by the complete HIV-LTR (data not shown).
The Tax protein from HTLV-1 is known as a potent inducer of NF-kB. It acts through several mechanisms including binding to p65 and p105, inactivation of IkBa or IkB-b and dissociation of the p100/NF-kB complexes (Kanno et al., 1994; Hiscott et al., 1995; Good and Sun, 1996; McKinsey et al., 1996; Rousset et al., 1996) . We therefore investigated whether Tax could induce NF-kB-dependent transcription in adenocarcinoma cells. MCF7 A/Z and MDA-MB-435 cells were thus cotransfected with the HIV-kB-CAT reporter plasmid and with a Tax expression vector ( Figure  8a ). In these conditions, Tax induced CAT activity in both cell types. Moreover, Tax did not transactivate a reporter gene driven by two mutated kB sites from the HIV-LTR (data not shown).
Selection of Tax-transfected MDA-MB-435 cells through cotransfection of an expression plasmid for the CD20 surface antigen and FACS sorting of CD20-expressing cells allowed us to demonstrate that Tax displaced p100 inhibitor from NF-kB complexes containing p65 (Figure 8b) . Eectively, the amount of p100 inhibitor associated to p65 is higher in cells expressing CD20 than in cells expressing both CD20 and Tax proteins, while Tax did not increase the processing of p100 into p52, as indicated by the unchanged amounts of both proteins. p100 antisense oligonucleotides restore induction of NF-kB-dependent transcription in MDA-MB-435 cells
To further con®rm the role of p100 in the inhibition of NF-kB in MDA-MB-435 cells, these cells were transfected with the 3xNF-kB(pIC)-tk-LUC reporter plasmid together with sense or antisense NFKB2/p100 oligonucleotides. Transfection of sense oligonucleotides did not modify the weak induction of LUC activity by TNF-a (Figure 9 ). Transfection of antisense p100 oligonucleotides allowed an increase in TNF-astimulated NF-kB-dependent transcription of the reporter gene. However, we could not reach an induction of LUC activity as strong as in MCF7 A/Z cells (compare with Figure 7b) . To evaluate the level of inhibition of p100 expression, we cotransfected the cells with a CD20 surface antigen expressing plasmid and enriched the population of positively transfected cells by FACS sorting. We were thus able to con®rm by immunoblotting that antisense p100 oligonucleotides eciently, but only partially, suppressed p100 expression (data not shown). Such a partial inhibition of p100 expression is probably related to p100 very long half-life. The ®gure shows the relative CAT activity after cotransfection with 1 mg of PMT2T-Tax expression vector over the activity observed without Tax. The total amount of transfected DNA (5 mg) was kept constant throughout the experiment by adding appropriate amounts of the expression vector without insert. Each value represents the mean of a minimum of three independent experiments after normalization to the protein concentration of the extracts. (b) MDA-MB-435 cells were transfected with a CD20 expression plasmid (1 mg) alone and in combination with a Tax expression plasmid (1 mg). Cytoplasmic extracts from positive CD20-expressing cells were analysed, directly (Western analysis) or after p65 immunoprecipitation (IP with anti-p65), on immunoblots revealed with antibodies directed against p100/p52 and Tax proteins 
Stable expression of p100 inhibits TNF-a-induced transcription of NF-kB-dependent promoters
To con®rm that p100 expression was responsible for the impaired NF-kB-dependent transcription following TNF-a stimulation, we stably transfected MCF7 A/Z with a pcDNA3-HA-p100 expression vector coding for a p100 protein linked to an hemagglutinin (HA) epitope. Immunoblots identi®ed two clones that expressed high levels of the HA-p100 protein (data not shown). Immunoprecipitations with p65 antibodies followed by immunoblots revealed with antibodies against HA, p100 or IkB-a showed that p65 is associated with p100 in the stable transfectant while it is not associated anymore with IkB-a (Figure 10 , compare the pc-HA-p100 clone with the control clone stably transfected with an empty pcDNA3 vector).
TNF-a stimulation of MCF7 A/Z cells stably transfected with the HA-p100 construct or with the empty expression vector (pcDNA3) induced NF-kB DNA-binding activity but this activity was considerably lower in HA-p100-expressing cells (Figure 11 ). EMSAs performed with an Oct-1 probe con®rmed that equivalent amounts of nuclear proteins were loaded in each lane.
The same stable transfectants were used to test the NF-kB-dependent transactivation in transient transfection experiments. MCF7 A/Z cells stably transfected with HA-p100 or with the empty pcDNA3 vector were transiently transfected with the 3xNF-kB(pIC)-tk-LUC reporter plasmid. Stimulation with TNF-a for 6 h generated a strong transactivation in the control pcDNA3 clone and a much weaker one in HA-p100 expressing cells (Figure 12a) . In a separate experiment, the same stably transfected clones were transiently transfected with the HIV-kB-CAT reporter plasmid. Figure 10 p65 cytoplasmic sequestration by p100 and IkB-a in HA-p100-stably transfected MCF7 A/Z cells. Cytoplasmic protein extracts (300 mg) from the stable transfectants were immunoprecipitated with a speci®c anti-p65 antibody and the immunoprecipitated material was analysed on immunoblots with antibodies recognizing the HA epitope (top panel), p100 (middle panel) and IkB-a (lower panel). The same blot was successively analysed by the three dierent antibodies Figure 11 p100 stable expression in MCF7 A/Z cells inhibits NF-kB induction by TNF-a. MCF7 A/Z cells stably transfected with an empty vector (pcDNA3) or with the HA-p100-encoding vector (pc-HA-p100) were stimulated with TNF-a for the indicated times. Nuclear extracts (4 mg of proteins) from untreated cells or TNF-a-treated cells were analysed on EMSAs with a labelled probe corresponding to a palindromic kB site. For competition assays, a 206 molar excess of unlabelled wild type (wt) or mutated (mut) probe was added to the binding reactions with nuclear extracts from cells stimulated for 360 min. The same extracts were analysed with an Oct-1 probe to con®rm that equivalent amounts of nuclear proteins had been loaded in each lane (pcDNA3) or with the HA-p100-encoding vector (pc-HA-p100) were transiently transfected with the 3xNF-kB(pIC)-tk-LUC (0.5 mg) reporter plasmid. Twenty-four hours after transfection, the cells were treated for 6 h with TNF-a (100 U/ml), harvested and LUC activities were determined. Similar data were obtained with a second MCF7 A/ Z HA-p100 clone (data not shown). (b) The same cells were cotransfected with 1 mg of a reporter plasmid containing a CAT gene driven by the two kB sites from the HIV virus (HIV-kB-CAT) and 1 mg of a PMT2T-Tax expression vector. CAT activities were measured as in Figures 7 and 8 Cotransfection of the Tax expression vector generated a strong transactivation of the reporter plasmid in both transfectants (Figure 12b ). These data thus indicated that p100-expressing MCF7 A/Z cells behaved just as MDA-MB-435 cells in response to TNF-a.
Discussion
The present report explored NF-kB constitutive and induced activity in adenocarcinoma cells as well as the relative expression of the dierent IkB inhibitors. Several cell lines showed high constitutive NF-kB activity which is often associated with low IkBa expression, con®rming recent reports demonstrating a constitutive NF-kB activity in breast cancer cells (Nakshatri et al., 1997; Sovak et al., 1997) . Moreover, our experiments indicated that the level of basal NF-kB activity varied considerably from one cell line to another.
Cell lines in which p100 is the major inhibitor demonstrated a reduced NF-kB nuclear translocation and a weak gene transcription following stimulation with TNF-a, IL-1b or PMA. On the other hand, cells that expressed predominantly IkB-a responded to NFkB activating stimuli by NF-kB nuclear translocation and gene transcription. We had previously reported increased expression of p100 in primary human breast cancers as compared to primary human mammary epithelial cells and to normal breast tissue (Dejardin et al., 1995) .
Cell stimulation with a number of stimuli (TNF-a, IL-1b, PMA) did not generate p100 processing and NF-kB-dependent transactivation in MDA-MB-435 cells or in p100-transfected MCF7 A/Z cells. The HTLV-1 Tax protein was the only agent we tested that could induce a signi®cant NF-kB transcriptional activity in p100-expressing cells, but Tax dissociated the NF-kB/p100 complexes without inducing p100 processing (Kanno et al., 1994) . In other words, our experiments so far failed to identify the agents that could trigger p100 phosphorylation and cleavage. In the literature, several reports con®rmed that p100 is very slowly processed (Betts and Nabel, 1996; Ishikawa et al., 1997) while a single study has successfully demonstrated p100 processing into p52 following PMA stimulation in HeLa cells (Mercurio et al., 1993) . It is thus likely that p100 represents a very stable NF-kB inhibitor which responds speci®cally to unidenti®ed stimuli dierent from those activating NF-kB through degradation of IkB-a, IkB-b or IkB-e. Dierences in p100 and IkB-a functions are also illustrated by the distinct phenotypes of knockout animals (Beg et al., 1995; Klement et al., 1996; Ishikawa et al., 1997) .
The biological role of p100 remains largely unknown. Knockout of the nfkb2 gene induced defects in B cell-mediated immune responses and in splenic microarchitecture (Caamano et al., 1998; while double nfkb1 and nfkb2 knockout animals failed to generate mature osteoclasts and B cells, indicating some overlap between the function of these two genes (Franzoso et al., 1997; Iotsova et al., 1997) . The knockout of the carboxy-terminal domain of p100 has also been reported (Ishikawa et al., 1997) . These animals develop gastric and lymph nodes hyperplasia and showed increased proliferation of lymphocytes in response to stimuli. These data therefore indicate that p100 plays a role in the control of epithelial and lymphoid cells proliferation as also suggested by the deletion of the p100 ankyrin repeats domain in some lymphoid malignancies (Neri et al., 1991; Fracchiola et al., 1993; Chang et al., 1995) .
Previous studies stated that, while IkB-a or IkB-b mostly controlled the activity of NF-kB-p50/p65 complexes and IkB-e associated preferentially with cRel and p65, p100 regulated the activity of RelBcontaining complexes (Dobrzanski et al., 1994 (Dobrzanski et al., , 1995 Lernbecher et al., 1994) . However, the present report demonstrates that p100, when highly expressed in adenocarcinoma cells, also sequestered most of p65 complexes in the cytoplasm. In these cells, p100 appeared to be the major NF-kB inhibitor and was able to block the induction of NF-kB-dependent transcription.
In MDA-MB-435 cells, TNF-a stimulation led to the degradation of IkB-a and IkB-b ( Figure 5 ) and high IkB-b expression was detected in most cell lines which express high levels of p100 (Figure 1b) . Simultaneously, we observed a weak but detectable induction of NF-kB nuclear DNA-binding activity after stimulation of p100-expressing cells, while, in the same conditions, we detected only a very weak transcriptional activity. Two possibilities could account for such an observation either the induced DNA-binding activity was too weak to launch signi®cant gene transcription, or NFkB associated with an inhibitor in the nucleus. Several authors suggested that IkB-a can translocate to the nucleus and capture NF-kB complexes (Zabel et al., 1993; Arenzana-Seisdedos et al., 1995; Tran et al., 1997) . IkB-a nuclear localization was indeed observed, especially when highly expressed and partially unbound to NF-kB. As highly expressed p100 competes with IkB-a for binding to p50/p65 in the cytoplasm, it is conceivable that some free IkB-a translocates to the nucleus and inhibits NF-kB-dependent gene transcription. However, immunoprecipitations and immunoblots performed on nuclear extracts from MDA-MB-435 cells failed to detect any IkB-a nuclear expression (data not shown).
Another putative nuclear inhibitor of NF-kB transcriptional activity could have been, at least in breast cancer cells, the Estrogen (ER) or the Progesterone (PR) receptor. Indeed, ER and PR can directly interact with p65 and inhibit p65-dependent transactivation (Ray et al., 1994; Stein and Yang, 1995; Kalkhoven et al., 1996) . However, MDA-MB-435 cells which failed to transactivate kB-dependent reporter plasmids are ER-negative. Moreover, among the breast cancer cell lines we analysed, only the T47D cell line expressed the PR (data not shown). We can thus conclude that ER and PR are not responsible for the inhibition of NF-kB-dependent transcription in p100-expressing breast cancer cells.
It is thus likely, at our opinion, that the absence of signi®cant gene transcription in p100-expressing stimulated cells is related to the partial inhibition of NF-kB nuclear induction. The weak NF-kB induced nuclear activity is probably not sucient to trigger the transcription of the reporter gene.
The signi®cance of our observations in cancer cells remains to be established. It has been recently reported that basal NF-kB activity protects breast cancer cells from apoptosis (Sovak et al., 1997) . In the panel of cell lines we examined, p100 expression was compatible with constitutive NF-kB activity and could thus allow such an anti-apoptotic action. We suggest that in these cells, p100 would allow constitutive NF-kB activity, presumably through a spontaneous, low rate dissociation of the p100/NF-kB complexes. It has indeed been demonstrated that p100 transfection increases basal NF-kB activity in NIH3T3 cells (Bitar et al., 1995) . Moreover, as the promoter of NFKB2/p100 contains several kB sites (Liptay et al., 1994; Oswald et al., 1998) , it is likely that the constitutive NF-kB activity induces p100 expression in these cell lines. After cellular stimulation with TNF-a, p100 is likely to inhibit the expression of inducible NF-kB target genes. Indeed, recent data obtained in our laboratory (Deregowski et al., unpublished observation) con®rmed that highly expressed p100 competes with IkBa for p65 sequestration in adenocarcinoma cells and thus inhibits NF-kB activation and NF-kB-dependent gene transcription in response to TNF-a. Among these genes whose induced expression is down-regulated in the presence of p100, we identi®ed several genes involved in the control of apoptosis and immune response. It is thus possible that p100 expression modi®es the response of cancer cells to the immune system. Further experiments will be designed to evaluate the role of basal and inducible NF-kB activity as well as p100 function in breast cancer cells.
Materials and methods
Cell culture and cell lines
MCF7 A/Z cells were kindly provided by Professor Mareel (University of Gent, Belgium). MDA-MB-435 cells were obtained from Dr J Price (University of Texas, Houston, TX, USA). HT-29 and their metastatic subclones HTM-29 were obtained from Dr E Kohn (National Institutes of Health, Bethesda, MD, USA). BT-474, MDA-MB-231, MDA-MB-453, MDA-MB-468, T47D, OVCAR-3 and Cos-7 cell lines were purchased from ATTC (Rockville, MD, USA). HCT116 and SW480 cell lines were purchased from the ECACC (Salisbury, UK). The various transformed cell lines were grown in RPMI 1640, Ham's F-12, McCoy's 5a, DMEM or Leibovitz's L-15 (Life Technologies) supplemented with 10% or 15% of fetal bovine serum, 2 mM glutamine, penicillin (100 U/ml) and streptomycin (100 mg/ ml) at 378C in a humidi®ed atmosphere with 5% CO 2 as recommended by the ATCC or the ECACC. TNF-a (Tumor Necrosis Factor-a) and IL-1b (Interleukin-1b) were purchased from Boehringer Mannheim and PMA (phorbol 12-myristate 13-acetate) from Sigma.
Cellular extracts and protein quanti®cation
Nuclear and cytoplasmic extracts for EMSA and immunoblots were prepared as described (Abmayr and Workman, 1990) . Protein amounts were quanti®ed with the Micro BCA Protein Assay Reagent Kit (Pierce) using a BSA (bovine serum albumin) standard solution as a reference.
Immunoblots
Protein extracts were separated by electrophoresis on SDS ± PAGE gel and then blotted on polyvinylidene di¯uoride membrane (PVDF, Millipore). After blocking for 16 h at room temperature with TBS-T buer plus 5% of non-fat milk, the blots were revealed with an appropriate ®rst antibody and a secondary antibody coupled to horseradish peroxydase (DAKO). The antigenantibody complex was visualized by a chemiluminescence method (ECL kit, Amersham). Each gel was stained with Coomassie blue after transfer to con®rm that equivalent amounts of proteins were loaded in every lane. The following antibodies were used to detect NF-kB and IkB members: an anti-p100/p52 monoclonal antibody (Upstate Biotechnology Inc., 05-361), an anti-peptide antibody directed against amino acids 531 ± 550 of p65 and an anti-peptide antibody directed against amino acids 339 ± 358 of IkB-b (Santa Cruz Biotechnology Inc., sc-372 and sc-945), an anti-peptide antibody directed against 13 amino-terminal amino acids of p50 (Dr U Siebenlist, National Institutes of Health, USA), a monclonal antibody directed against amino acids 21 ± 48 of IkB-a (Mad10B) (Dr K Wood, Freeman Hospital, Newcastle, UK). The monoclonal anti-HA antibody (clone 12CA5) was purchased from Boehringer Mannheim. The monoclonal anti-Tax antibody was provided by Dr J Brady (National Institutes of Health, Bethesda, MD, USA).
Immunoprecipitations
Cells were lysed in TNT buer for cytoplasmic extracts (Rice et al., 1992) . Lysates were cleared by centrifugation at 10 000 g for 10 min. Protein extracts were immunoprecipitated with speci®c anti-peptide antibody directed against the 14 N-terminal amino acids following the initiator methionine of p65 (Dr U Siebenlist, National Institutes of Health, USA) in a total volume of 700 ml. Precipitates were collected on protein A-Sepharose beads CL-4B (Pharmacia Biotech). After intensive washing, the antigen-antibody complexes were separated by SDS ± PAGE, transferred to a PVDF membrane and revealed by immunoblots as described above.
Electrophoretic mobility shift assays
Nuclear extracts were prepared as previously described (Dejardin et al., 1995) . The palindromic kB, the Oct-1 and the AP-1 probes carried respectively the following sequences: 5'-TTGGCAACGGCAGGGGAATTCCCCTC-TCCT-3', 5'-TCGAGCCTATTTGCATCTA-3' and 5'-GATCTCATGACTCAGAGGAAAA-3'. Supershifting experiments were performed by incubating the speci®c antibody with the nuclear proteins on ice for 30 min prior to incubation for 15 min at room temperature with the 32 Plabelled probe. The anti-peptide antibodies used for the supershifts experiments were: an anti-p50 antibody directed against amino acids 1 ± 12 and an anti-p52/p100 antibody directed against amino acids 4 ± 19 (Dr U Siebenlist, National Institutes of Health, USA), an anti-p65 antibody directed against the 13 carboxy-terminal amino acids (Upstate Biotechnology Inc., 06-418), the anti-c-Rel antiserum 1136 (Dr N Rice, NCI, Frederick, USA) and an anti-RelB antibody directed against amino acids 540 ± 558 (Santa Cruz Biotechnology Inc., sc-226).
Plasmid constructs
Expression vectors encoding p100/p52, p105/p50, IkB-a, IkB-b, p65(RelA) and p50 were constructed by subcloning the respective cDNA into pcDNA3 expression vector (Invitrogen Corp.) at the BamHI ± EcoRV, EcoRI ± XhoI, EcoRI, NotI, NotI ± XhoI and EcoRI ± NotI restriction sites, respectively. To obtain the pcDNA3-HA-p100 expression vector, we introduced by PCR a ClaI restriction site upstream of the second codon of the p100 cDNA, allowing the cloning of a double strand oligonucleotide containing a 5' Kozak consensus sequence followed by a sequence encoding an initial methionine and the HA epitope (YPYDVPDYA). PCR products were checked by sequencing both strands. The reporter constructs kB-CAT were previously described Franzoso et al., 1993) . The 3xNF-kB(pIC)-tk-LUC plasmid reporter was kindly provided by Dr B van der Burg (Hubrecht Laboratory, Utrecht, Netherlands). The expression vector PMT2T-Tax was previously described (Kanno et al., 1994) . The expression vector pCMV-CD20 was provided by Dr J Koh (MGH Cancer Center, Charlestown, MA, USA).
Transfection of oligonucleotides
Synthetic phosphorothioate sense and antisense oligonucleotides for p100/p52 were purchased from Eurogentec. The sequence of the sense oligonucleotides is 5'-GACATG-GAGAGTTGCTACAACCCA-3' and the sequence of the antisense oligonucleotide corresponds to the complementary strand spanning the translation initiation site. Cells plated in six-well culture dishes were treated with a mix containing 0.5 mg of oligonucleotides, 4.5 mg of carrier DNA (pcDNA3) and 15 mg of DOTAP (Boehringer Mannheim) during 6 h at 378C. The medium was then removed and replaced by fresh medium. After 24 h, cells were left untreated or stimulated with TNF-a during 6 h at 378C and luciferase activity was determined as described below.
Transient transfection, CAT and luciferase assays
For DNA transfection, cells were plated in six-well culture dishes at a 40% con¯uence. The following day, the cells (MDA-MB-435, MDA-MB-231 and MCF7 A/Z) were transfected with the DOTAP reagent or (Cos-7) with the Dosper reagent (Boehringer Mannheim). Cells were harvested after 48 h (CAT) or 30 h (LUC) for the determination of the chloramphenicol acetyltransferase (CAT) activity or luciferase (LUC) activity. CAT activity was determined as described before (Bours et al., 1994) and LUC activity was determined as recommended by the manufacturer (Boehringer Mannheim).
Stable transfectants
The MCF7 A/Z cells were transfected with the linearized pcDNA3 empty vector or with the pcDNA3-HA-p100 vector using the DOTAP system (Boehringer Mannheim). Forty-eight hours after transfection, transfected cells were selected in a medium containing G418 at 0.5 mg/ml. After 15 days of selection, 20 resistant colonies were isolated and grown separately. Positive clones were selected by detection of HA-p100 fusion protein in cytoplasmic extracts using an antibody directed against the HA epitope.
Cell sorting
MDA-MB-435 cells transiently transfected with the CD20 expression vector were isolated by FACS sorting. Twentyfour hours after transfection, the cells were treated with Dispase II (Boehringer Mannheim) and washed two times with cold PBS (Life Technologies). The cells were then incubated in PBS for 30 min at 48C with a phycoerythrin anti-CD20 (Leu-16) monoclonal antibody (Becton Dickinson) at a concentration of 0.5 mg/10 6 cells. The cells (75610 6 ) were then washed three times in PBS and resuspended at 5610 6 cells/ml. Positive CD20-expressing cells were isolated by¯ow cytometry (FACStar + , Becton Dickinson).
